. 2019; 8(1): 26-30 | DOI: 10.5505/respircase.2019.43433 | |||
Pulmonary Toxicity Secondary to Fluorouracil, Leucoverin and Oxaliplatin Treatment: A Case ReportFatma Tokgöz Akyıl1, Mustafa Akyil2, Erdem Şen3, Meltem Ağca4, Tülin Sevim41Canakkale State Hospital, Pulmonology2Canakkale State Hospital, Thoracic Surgery 3Canakkale State Hospital, Oncology 4Sureyyapasa Chest Diseases And Thoracic Surgery Training And Research Hospital, Pulmonology To date, 5-fluorourasil, leucovorin, and oxaliplatin (FOLFOX) continues to be used as a first-line treatment for advanced or metastatic gastrointestinal system tumors. Though associated hematological, gastrointestinal, and neurosensory toxicities are widely known, pulmonary toxicity has solely been described in case reports. Early diagnosis and treatment is extremely important, since the toxicity may lead to rapid deterioration and mortality. Presently described is the case of a female patient with interstitial lung disease secondary to undergoing a FOLFOX regimen for metastatic esophagus cancer. Keywords: drug toxicity, interstitial lung disease, oxaliplatinFluorourasil, Leucoverin ve Oxaliplatin Tedavisine Sekonder Akciğer Toksistesi: Olgu SunumuFatma Tokgöz Akyıl1, Mustafa Akyil2, Erdem Şen3, Meltem Ağca4, Tülin Sevim41Çanakkale Devlet Hastanesi, Göğüs Hastalıkları2Çanakkale Devlet Hastanesi, Göğüs Cerrahisi 3Çanakkale Devlet Hastanesi, Onkoloji 4Sureyyapaşa Göğüs Hastalıkları Ve Göğüs Cerrahisi Eğitim Ve Araştırma Hastanesi, Göğüs Hastalıkları Günümüzde, FOLFOX (5-fluorourasil, leucoverin ve oxaliplatin) ileri evre veya metastatik Tomography Slices of the Case
Tedavi Sonrası
Fatma Tokgöz Akyıl, Mustafa Akyil, Erdem Şen, Meltem Ağca, Tülin Sevim. Pulmonary Toxicity Secondary to Fluorouracil, Leucoverin and Oxaliplatin Treatment: A Case Report. . 2019; 8(1): 26-30 Corresponding Author: Fatma Tokgöz Akyıl, Türkiye |
|